1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > Asia-Pacific Infectious Diagnostics Market Outlook to 2021

Asia-Pacific Infectious Diagnostics Market Outlook to 2021

  • October 2015
  • -
  • Global Data
  • -
  • 105 pages

Asia-Pacific Infectious Diagnostics Market Outlook to 2021

Summary

GlobalData’s new report, "Asia-Pacific Infectious Diagnostics Market Outlook to 2021", provides key market data on the Asia-Pacific Infectious Diagnostics market. The report provides value, in millions of US dollars within market segments - Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Infectious Diagnostics market includes Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Infectious Diagnostics market.
- Global corporate-level profiles of key companies operating within the Asia-Pacific Infectious Diagnostics market.
- Key players covered include Siemens Healthcare, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Hologic, Inc., Qiagen N.V., Becton, Dickinson and Company, Danaher Corporation and Alere Inc..

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

Asia-Pacific Infectious Diagnostics Market Outlook to 2021
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 What Is This Report About? 7
2.2 Infectious Diagnostics Market Segmentation 7
2.3 Definitions of Markets Covered in the Report 8
3 Infectious Diagnostics Market, Asia-Pacific 10
3.1 Infectious Diagnostics Market, Asia-Pacific, Revenue ($m), 2007-2021 10
3.2 Infectious Diagnostics Market, Asia-Pacific, Category Comparison by Revenue ($m), 2007-2021 12
3.3 Infectious Diagnostics Market, Asia-Pacific, Revenue ($m), 2007-2014 14
3.4 Infectious Diagnostics Market, Asia-Pacific, Revenue ($m), 2014-2021 16
3.5 Infectious Diagnostics Market, Asia-Pacific, Company Share by Revenue ($m), 2014 18
4 Infectious Diagnostics Market, Australia 20
4.1 Infectious Diagnostics Market, Australia, Revenue ($m), 2007-2014 20
4.2 Infectious Diagnostics Market, Australia, Revenue ($m), 2014-2021 22
4.2.1 Infectious Diagnostics Rapid Tests and POC Market, Australia, Revenue ($m), by Segment, 2007-2014 24
4.2.2 Infectious Diagnostics Rapid Tests and POC Market, Australia, Revenue ($m), by Segment, 2014-2021 26
4.3 Infectious Diagnostics Market, Australia, Distribution Share by Revenue ($m), 2013-2014 28
4.4 Infectious Diagnostics Market, Australia, Company Share by Revenue ($m), 2014 29
5 Infectious Diagnostics Market, China 31
5.1 Infectious Diagnostics Market, China, Revenue ($m), 2007-2014 31
5.2 Infectious Diagnostics Market, China, Revenue ($m), 2014-2021 33
5.2.1 Infectious Diagnostics Rapid Tests and POC Market, China, Revenue ($m), by Segment, 2007-2014 35
5.2.2 Infectious Diagnostics Rapid Tests and POC Market, China, Revenue ($m), by Segment, 2014-2021 37
5.3 Infectious Diagnostics Market, China, Distribution Share by Revenue ($m), 2013-2014 39
5.4 Infectious Diagnostics Market, China, Company Share by Revenue ($m), 2014 40
6 Infectious Diagnostics Market, India 42
6.1 Infectious Diagnostics Market, India, Revenue ($m), 2007-2014 42
6.2 Infectious Diagnostics Market, India, Revenue ($m), 2014-2021 44
6.2.1 Infectious Diagnostics Rapid Tests and POC Market, India, Revenue ($m), by Segment, 2007-2014 46
6.2.2 Infectious Diagnostics Rapid Tests and POC Market, India, Revenue ($m), by Segment, 2014-2021 48
6.3 Infectious Diagnostics Market, India, Distribution Share by Revenue ($m), 2013-2014 50
6.4 Infectious Diagnostics Market, India, Company Share by Revenue ($m), 2014 51
7 Infectious Diagnostics Market, Japan 53
7.1 Infectious Diagnostics Market, Japan, Revenue ($m), 2007-2014 53
7.2 Infectious Diagnostics Market, Japan, Revenue ($m), 2014-2021 55
7.2.1 Infectious Diagnostics Rapid Tests and POC Market, Japan, Revenue ($m), by Segment, 2007-2014 57
7.2.2 Infectious Diagnostics Rapid Tests and POC Market, Japan, Revenue ($m), by Segment, 2014-2021 59
7.3 Infectious Diagnostics Market, Japan, Distribution Share by Revenue ($m), 2013-2014 61
7.4 Infectious Diagnostics Market, Japan, Company Share by Revenue ($m), 2014 62
8 Infectious Diagnostics Market, South Korea 64
8.1 Infectious Diagnostics Market, South Korea, Revenue ($m), 2007-2014 64
8.2 Infectious Diagnostics Market, South Korea, Revenue ($m), 2014-2021 66
8.2.1 Infectious Diagnostics Rapid Tests and POC Market, South Korea, Revenue ($m), by Segment, 2007-2014 68
8.2.2 Infectious Diagnostics Rapid Tests and POC Market, South Korea, Revenue ($m), by Segment, 2014-2021 70
8.3 Infectious Diagnostics Market, South Korea, Distribution Share by Revenue ($m), 2013-2014 72
8.4 Infectious Diagnostics Market, South Korea, Company Share by Revenue ($m), 2014 73
9 Overview of Key Companies in Asia-Pacific Infectious Diagnostics Market 75
9.1 Abbott Laboratories 75
9.1.1 Company Overview 75
9.2 F. Hoffmann-La Roche Ltd. 75
9.2.1 Company Overview 75
9.3 Siemens Healthcare 75
9.3.1 Company Overview 75
9.4 Danaher Corporation 76
9.4.1 Company Overview 76
9.5 Transasia Bio-Medicals Ltd. 76
9.5.1 Company Overview 76
9.6 Qiagen N.V. 76
9.6.1 Company Overview 76
9.7 Bio-Rad Laboratories, Inc. 77
9.7.1 Company Overview 77
9.8 Alere Inc. 77
9.8.1 Company Overview 77
9.9 Becton, Dickinson and Company 77
9.9.1 Company Overview 77
9.10 bioMerieux S.A. 78
9.10.1 Company Overview 78
9.11 Hologic, Inc. 78
9.11.1 Company Overview 78
9.12 DiaSorin S.p.A 78
9.12.1 Company Overview 78
10 Infectious Diagnostics Market Pipeline Products 79
11 Recent Developments 91
11.1 Corporate Communications 91
11.1.1 Dec 04, 2014: Neogen names COO 91
11.2 Financial Announcements 91
11.2.1 Jul 21, 2015: Neogen reports record revenues and earnings 91
11.2.2 May 09, 2015: Shanghai MicroPort Orthopedics Hosts First SuperPath Online Symposium 93
11.2.3 Mar 26, 2015: Neogen reports 13% increase in net income 93
11.2.4 Mar 18, 2015: Blue Belt Technologies Announces First Navio Case Performed in Australia and First Navio-assisted GRU Unicompartmental Knee Replacement 95
11.2.5 Dec 31, 2014: MicroPort Completes First Implantation of Reewarm18 96
11.2.6 Dec 18, 2014: Neogen reports 26% increase in net income 97
11.3 Other Significant Developments 99
11.3.1 Jun 11, 2015: Lansen subsidiary signs a distribution agreement with Bio-Rad China and expands into the clinical diagnostic market in the PRC 99
11.3.2 Nov 05, 2014: Bearing Analytics Changes Name To DATTUS, Opens Office In India 99
11.4 Product News 100
11.4.1 Nov 19, 2014: Seegene Receives US Patent for TOCE Technology 100
11.5 Strategy And Business Planning 101
11.5.1 May 19, 2015: QIAGEN opens new office in Kuala Lumpur as business expands in Malaysia 101
12 Appendix 102
12.1 Research Methodology 103
12.1.1 Coverage 103
12.1.2 Secondary Research 103
12.1.3 Primary Research 103
12.1.4 Company Share Analysis 104
12.1.5 Distribution Share Analysis 104
12.2 GlobalData Consulting 104
12.3 Contact Us 104
12.4 Disclaimer 105

1.1 List of Tables
Table 1: Infectious Diagnostics Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2007-2021 11
Table 2: Infectious Diagnostics Market, Asia-Pacific, Category Comparison by Revenue ($m), USD Constant, 2007-2021 13
Table 3: Infectious Diagnostics Market, Asia-Pacific, Revenue ($m), Historic, USD Constant, 2007-2014 15
Table 4: Infectious Diagnostics Market, Asia-Pacific, Revenue ($m), Forecast, USD Constant, 2014-2021 17
Table 5: Infectious Diagnostics Market, Asia-Pacific, Company Share by Revenue ($m), USD Constant, 2014 19
Table 6: Infectious Diagnostics Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 21
Table 7: Infectious Diagnostics Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 23
Table 8: Infectious Diagnostics Rapid Tests and POC Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 25
Table 9: Infectious Diagnostics Rapid Tests and POC Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 27
Table 10: Infectious Diagnostics Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2013-2014 28
Table 11: Infectious Diagnostics Market, Australia, Company Share by Revenue ($m), USD Constant, 2014 30
Table 12: Infectious Diagnostics Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 32
Table 13: Infectious Diagnostics Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 34
Table 14: Infectious Diagnostics Rapid Tests and POC Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 36
Table 15: Infectious Diagnostics Rapid Tests and POC Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 38
Table 16: Infectious Diagnostics Market, China, Distribution Share by Revenue ($m), USD Constant, 2013-2014 39
Table 17: Infectious Diagnostics Market, China, Company Share by Revenue ($m), USD Constant, 2014 41
Table 18: Infectious Diagnostics Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 43
Table 19: Infectious Diagnostics Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 45
Table 20: Infectious Diagnostics Rapid Tests and POC Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 47
Table 21: Infectious Diagnostics Rapid Tests and POC Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 49
Table 22: Infectious Diagnostics Market, India, Distribution Share by Revenue ($m), USD Constant, 2013-2014 50
Table 23: Infectious Diagnostics Market, India, Company Share by Revenue ($m), USD Constant, 2014 52
Table 24: Infectious Diagnostics Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 54
Table 25: Infectious Diagnostics Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 56
Table 26: Infectious Diagnostics Rapid Tests and POC Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 58
Table 27: Infectious Diagnostics Rapid Tests and POC Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 60
Table 28: Infectious Diagnostics Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2013-2014 61
Table 29: Infectious Diagnostics Market, Japan, Company Share by Revenue ($m), USD Constant, 2014 63
Table 30: Infectious Diagnostics Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 65
Table 31: Infectious Diagnostics Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 67
Table 32: Infectious Diagnostics Rapid Tests and POC Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 69
Table 33: Infectious Diagnostics Rapid Tests and POC Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 71
Table 34: Infectious Diagnostics Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2013-2014 72
Table 35: Infectious Diagnostics Market, South Korea, Company Share by Revenue ($m), USD Constant, 2014 74
Table 36: Infectious Diagnostics Market Pipeline Products 79

1.2 List of Figures
Figure 1: Infectious Diagnostics Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2007-2021 10
Figure 2: Infectious Diagnostics Market, Asia-Pacific, Category Comparison by Revenue ($m), USD Constant, 2007-2021 12
Figure 3: Infectious Diagnostics Market, Asia-Pacific, Revenue ($m), Historic, USD Constant, 2007-2014 14
Figure 4: Infectious Diagnostics Market, Asia-Pacific, Revenue ($m), Forecast, USD Constant, 2014-2021 16
Figure 5: Infectious Diagnostics Market, Asia-Pacific, Company Share (%) 2014 18
Figure 6: Infectious Diagnostics Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 20
Figure 7: Infectious Diagnostics Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 22
Figure 8: Infectious Diagnostics Rapid Tests and POC Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 24
Figure 9: Infectious Diagnostics Rapid Tests and POC Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 26
Figure 10: Infectious Diagnostics Market, Australia, Company Share (%) 2014 29
Figure 11: Infectious Diagnostics Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 31
Figure 12: Infectious Diagnostics Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 33
Figure 13: Infectious Diagnostics Rapid Tests and POC Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 35
Figure 14: Infectious Diagnostics Rapid Tests and POC Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 37
Figure 15: Infectious Diagnostics Market, China, Company Share (%) 2014 40
Figure 16: Infectious Diagnostics Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 42
Figure 17: Infectious Diagnostics Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 44
Figure 18: Infectious Diagnostics Rapid Tests and POC Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 46
Figure 19: Infectious Diagnostics Rapid Tests and POC Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 48
Figure 20: Infectious Diagnostics Market, India, Company Share (%) 2014 51
Figure 21: Infectious Diagnostics Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 53
Figure 22: Infectious Diagnostics Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 55
Figure 23: Infectious Diagnostics Rapid Tests and POC Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 57
Figure 24: Infectious Diagnostics Rapid Tests and POC Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 59
Figure 25: Infectious Diagnostics Market, Japan, Company Share (%) 2014 62
Figure 26: Infectious Diagnostics Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 64
Figure 27: Infectious Diagnostics Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 66
Figure 28: Infectious Diagnostics Rapid Tests and POC Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 68
Figure 29: Infectious Diagnostics Rapid Tests and POC Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 70
Figure 30: Infectious Diagnostics Market, South Korea, Company Share (%) 2014 73

Companies mentioned
Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Siemens Healthcare
Danaher Corporation
Transasia Bio-Medicals Ltd.
Qiagen N.V.
Bio-Rad Laboratories, Inc.
Alere Inc.
Becton, Dickinson and Company
bioMerieux S.A.
Hologic, Inc.
DiaSorin S.p.A

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 12800
  • Industry report
  • August 2016
  • by Venture Planning Group

This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and ...

Europe Cancer Diagnostics Market Future Horizons and Growth Strategies: Supplier Shares by Tumor Marker, Country Segment Forecasts, Competitive Intelligence, Opportunities

Europe Cancer Diagnostics Market Future Horizons and Growth Strategies: Supplier Shares by Tumor Marker, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 12800
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800.VPGMarketResearch.com's new report is a strategic analysis of the major business opportunities emerging in the ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.